Papillary thyroid cancer in a patient with germline CHEK2 mutation: A case report

This publication has 13 references indexed in Scilit:

• Coexisting Germline CHEK2 and Somatic BRAF^V600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
  Cancers, 2019
• Identification of Rare Variants Predisposing to Thyroid Cancer
  Thyroid®, 2019
• The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population
  Hereditary Cancer in Clinical Practice, 2015
• CHEK2mutations and the risk of papillary thyroid cancer
  International Journal of Cancer, 2015
• Integrated Genomic Characterization of Papillary Thyroid Carcinoma
  Cell, 2014
• Variants in the ATM‐CHEK2‐BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma
  Genes, Chromosomes and Cancer, 2014
• Response to DNA damage of CHEK2 missense mutations in familial breast cancer
  Human Molecular Genetics, 2012
• Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
  European Journal of Human Genetics, 2006
• Rare Germ Line CHEK2 Variants Identified in Breast Cancer Families Encode Proteins That Show Impaired Activation
  Cancer Research, 2006
• CHEK2 Is a Multiorgan Cancer Susceptibility Gene
  The American Journal of Human Genetics, 2004